The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib

1. Armand, J.-P.
2. Burnett, A.K.
3. Drach, J.
4. Harousseau, J.-L.
5. Löwenberg, B.
6. San Miguel, J.